A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis
Objective: The objective of the study was to confirm the efficacy and safety of Astodrimer 1% Gel to prevent recurrence of bacterial vaginosis. Study design: 864 women with a diagnosis of bacterial vaginosis and a history of recurrent bacterial vaginosis were enrolled in North America and first rece...
Saved in:
Main Authors: | Jane R. Schwebke (Author), Belvia A. Carter (Author), Arthur S. Waldbaum (Author), Kathy J. Agnew (Author), Jeremy R.A. Paull (Author), Clare F. Price (Author), Alex Castellarnau (Author), Philip McCloud (Author), George R. Kinghorn (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial
by: Stephen Winchester, et al.
Published: (2024) -
Pilot Study to Evaluate the Appropriate Management of Patients With Coexistent Bacterial Vaginosis and Cervicitis
by: Jane R. Schwebke, et al.
Published: (1995) -
Differential diagnosis and treatment for bacterial vaginosis
by: Chilova R.A, et al.
Published: (2020) -
Effects of Pregnancy and Bacterial Vaginosis on Proinflammatory Cytokine and Secretory Leukocyte Protease Inhibitor Concentrations in Vaginal Secretions
by: Jennifer Balkus, et al.
Published: (2010) -
Tinidazole in the treatment of bacterial vaginosis
by: Nicola R Armstrong, et al.
Published: (2009)